The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity - Ali, S; Heathcote, DA; Kroll, SHB; Jogalekar, AS; Scheiper, B; Patel, H; Brackow, J; Siwicka, A; Fuchter, MJ; Periyasamy, M; Tolhurst, RS; Kanneganti, SK; et al. (CANCER RESEARCH, 2009)